Morning Market Losers

Biodel BIOD dropped 16.10% to $4.22 after the company's BIOD-123 achieved primary endpoint in Phase 2 Clinical trial demonstrating glycemic control comparable to Humalog. GW Pharmaceuticals plc GWPH plummeted 13.60% to $14.17. GW Pharmaceuticals' trailing-twelve-month profit margin is -14.81%. Orbital Corporation Limited OBT dropped 8.64% to $2.75 after the company announced its plans to cancel United States based ADR program. BioFuel Energy BIOF dropped 7.59% to $3.91. BioFuel Energy's trailing-twelve-month ROE is -53.62%.